more_reports

The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports

NY Biotech Has Potentially Game Changing Anxiety Therapy

Research Report
  ()
Mind Medicine (MindMed) Inc. recently announced positive results from its Phase 2b trial of MM120 in generalized anxiety disorder, according to a Roth MKM research note.
Tags:  Biotechnology / Pharmaceuticals

Alt-Pharma VC adds 7% Stake in Testing Strip Firm

  ()
Alt pharma is hot these days, and few companies are coming in hotter than Safe Supply Streaming Co. Ltd., which just secured a 7% stake in a leading medical test company to expand its functional portfolio.
Tags:  Biotechnology / Pharmaceuticals

Cash Rich Biotech Could Win a Lawsuit With Lilly, Expert Says

Contributed Opinion
  ()
Ron Struthers explains how the cash value of this biotech is about $1.68/share and the stock is selling at around -58% discount to cash value. He also discusses a recent lawsuit with Eli Lilly.
Tags:  Biotechnology / Pharmaceuticals

Drug Reformer Subsidiary Inspected for Dealer License

  ()
In a "transformative moment" for the company, a Safe Supply Streaming Co. Ltd. subsidiary has undergone an official inspection by Health Canada to acquire a dealer license to produce, distribute, and export controlled substances.
Tags:  Biotechnology / PharmaceuticalsCannabis

Leadership Cuts Won't Slow This Biotech

Research Report
  ()
While three executive officers have been cut from Kronos Bio Inc., it is still a Buy, according to an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Pharma Co. Primed for Future Business

Research Report
  ()
Analysts at Research Capital believe that Knight Therapeutics Inc. is primed to conduct future business development.
Tags:  Biotechnology / Pharmaceuticals

Healthcare Co. Exceeds Expectations in Performance

Research Report
  ()
Sensus Healthcare Inc. released fourth-quarter financials that surpassed expectations, according to an H.C. Wainwright & Co. research note.
Tags:  Healthcare ServicesBiotechnology / Pharmaceuticals

Money Manager: The Year of Small Caps?

  ()
The president and chief executive officer of Toronto-based AlphaNorth Asset Management says his positive outlook on 2024 has not changed. In fact, it could be a great year for small caps.
Tags:  Cobalt / Lithium / ManganeseBiotechnology / PharmaceuticalsSilverBattery MetalsGoldTechnologyAlternative - Cleantech

Showing Results: 26 to 33 of 33 Prev